| Ms Jeri L Dentz, CNM | |
|
8170 33rd Ave S, C/o Physician Services, Ms 21110q, Healthpartners Floating Clinic, Minneapolis, MN 55440-1309 | |
| (952) 883-5375 | |
| (952) 883-5395 |
| Full Name | Ms Jeri L Dentz |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 8170 33rd Ave S, C/o Physician Services, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952572778 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | R 142865-2 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jeri L Dentz, CNM 8170 33rd Ave S, Ms21110q, Minneapolis, MN 55425-4516 Ph: (952) 883-5375 | Ms Jeri L Dentz, CNM 8170 33rd Ave S, C/o Physician Services, Ms 21110q, Healthpartners Floating Clinic, Minneapolis, MN 55440-1309 Ph: (952) 883-5375 |
News Archive
Researchers at McMaster University (Hamilton, ON) explored whether a surgeon's expertise influences procedural choice. The results of a new study of more than 8000 non-small cell lung cancer (NSCLC) patients undergoing surgical resection by 124 physicians showed that surgeons who perform more surgeries are less likely to perform high-risk pneumonectomies. Christian J. Finley, MD, MPH, will be presenting the results of this research at the 95th AATS Annual Meeting in Seattle, WA on April 28, 2015.
Xenon Pharmaceuticals Inc. today announced the establishment of a new collaboration with Genentech, a member of the Roche Group, for pain genetics, with the goal of discovering and validating new therapeutic targets and mechanisms for treating pain.
OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, received approval from the European Commission for Tarceva as a monotherapy maintenance treatment in patients with advanced non-small cell lung cancer (NSCLC) whose disease remains largely unchanged (stable disease) after platinum-based initial chemotherapy.
Introgen Therapeutics, Inc. today reported the publication of preclinical data demonstrating that INGN 241 works synergistically with celecoxib (Celebrex) marketed by Pfizer to inhibit the growth and increase apoptosis (cell death) of breast cancer cells.
Some call such legislation an "overreach," but at least some of the proposals are getting political traction, including a push in Washington State this week to require insurance plans to cover abortion.
› Verified 1 days ago
Claire C Nelson, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-2203 Fax: 612-904-4273 | |
Pamela S.f. Glenn, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1200 Lagoon Ave, Minneapolis, MN 55408 Phone: 612-823-6300 | |
Susanna Goldstein, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3033 Excelsior Blvd, Minneapolis, MN 55416 Phone: 612-345-5920 | |
Heather Christopher, APRN, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2606 Chicago Ave, Minneapolis, MN 55407 Phone: 612-545-5311 | |
Olivia Lynn Fricke, CNM, APRN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1919 Nicollet Ave, Minneapolis, MN 55403 Phone: 719-580-9134 Fax: 612-236-4745 | |
Julia M Cross, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-2203 Fax: 612-904-4273 | |
Nancy L Schamber, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 701 Park Ave, Minneapolis, MN 55415 Phone: 612-873-2203 Fax: 612-904-4273 |